Cogent Biosciences, Inc. (NASDAQ:COGT – Get Free Report) has earned an average rating of “Moderate Buy” from the seven analysts that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price target among brokers […]
Cogent Biosciences, Inc. (NASDAQ:COGT) Given Consensus Recommendation of "Moderate Buy" by Analysts wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.
E Fund Management Co. Ltd. Acquires New Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences (NASDAQ:COGT) Releases Earnings Results, Misses Expectations By $0.11 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Analyzing TransCode Therapeutics (NASDAQ:RNAZ) & Cogent Biosciences (NASDAQ:COGT) modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.